Picture of Bausch Health Companies logo

BHC Bausch Health Companies Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapSuper Stock

Annual income statement for Bausch Health Companies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue8,6018,0278,4348,1248,757
Cost of Revenue
Gross Profit6,2515,7786,0405,7606,198
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses8,8467,4108,0466,7957,793
Operating Profit-2456173881,329964
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes-1,837-934-1,024-129-390
Provision for Income Taxes
Net Income After Taxes-1,783-559-937-212-611
Minority Interest
Net Income Before Extraordinary Items
Net Income-1,788-560-948-225-592
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-1,788-560-948-225-592
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-2.12-0.272-0.482-0.511-0.491